NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Not Yet RecruitingN/A

Sponsor: University of Maryland, Baltimore

Conditions: Breast Cancer (Locally Advanced or Metastatic), Healthy Volunteers (HV), Unhealthy Volunteers, Breast Cancer Screening

Interventions: Epigenetic Assay

Countries: United States

The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* 18 years old or older
* Patient of UMMS
* Willing and able to consent to study procedures listed in the protocol
* Ability to speak and understand English

Exclusion Criteria:

* Younger than 18 years old
* Patient not cared for at UMMS
* Unable to consent to study procedures listed in the protocol
* Unable to speak or understand English

Locations (1)

Glen Burnie, Maryland, United States